Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Lilly to participate in Bernstein's 2nd Annual Healthcare Forum
-
Lawdragon 500 Leading Litigators selects Nine KAS Lawyers
-
Bernstein Private Wealth Management Elevates New Leadership in Houston with Dual Appointments After Record Growth
-
CRH plc (CRH) PT Raised to $130 at Bernstein SocGen Group
-
Amrize Ltd (AMRZ) PT Raised to $65 at Bernstein SocGen Group
-
Maze Therapeutics reports positive phase 1 results for PKU, CKD drug
-
Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (
-
Bernstein Cuts Coloplast A/S (COLOB:DC) (CLPBY) Stock PT, Sees Attractive Opportunity to Build Position
-
Bernstein: Running the Numbers on Kraft Heinz's (KHC) Potential Deals After the Split
-
Bernstein Reiterates Outperform Rating on Walmart (WMT)
-
Oracle (ORCL) PT Raised to $363 at Bernstein 'As Growth Accelerates'
-
Oracle's cloud growth forecast 'rarely seen at this scale': Bernstein
-
Bernstein SocGen Group Starts Doosan Enerbility Co Ltd (034020:KS) at Outperform
-
This French stock has become too cheap to ignore, Bernstein says
-
GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
-
Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & He
-
Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims
-
Bernstein Private Wealth Management Hires Top Industry Talent to Accelerate Growth in Priority Regions
-
Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments
-
Bernstein lowers U.S. telecom stock targets on rising competition
-
'Out Top Pick Is Sonova Holding AG (SOON:SW) (SONVY)'; PT Raised at Bernstein
-
Bernstein: 'What Does Spirit's Bankruptcy Mean for the Industry?'
-
Bernstein Reiterates Outperform Rating on UnitedHealth Group (UNH)
-
RTX Corp. (RTX) PT Raised to $157 at Bernstein SocGen Group
-
Charter Communications (CHTR) PT Lowered at Bernstein, Reflecting 'Greater BB Losses'
-
Bernstein Positive on UnitedHealth Group (UNH): 'UNH seems to be signaling some stability ahead of 3Q earnings, releasing preliminary 2026 MA Stars results'
-
Frequency Electronics Announces First Quarter Fiscal 2026 Financial Results Conference Call: Thursday, September 11, 2025, at 4:30 PM ET
-
Bernstein SocGen Group Upgrades Novo Nordisk (NOVOB:DC) (NVO) to Outperform
-
Bernstein Weighs In on 'Positive Developments' for Lyft (LYFT) and Uber (UBER)
-
Bernstein on Robinhood Markets (HOOD): '5 Charts Show Significant Headroom in Market Share'
-
Bernstein on Circle Internet Group (CRCL): 'Hyperliquid Fears but USDC Market Share on a Tear'
-
INTRODUCING THIRD-GENERATION SOLAR: 1st Avenue Power Unveils the First Fully Integrated Clean Power System of the AI Era
-
Form 3 First Foundation Inc. For: Aug 11 Filed by: Bernstein Stuart Daniel
-
Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum
-
Form 485APOS BERNSTEIN SANFORD C FUND
-
Bernstein says weakness in this stock is an attractive opportunity to build exposure
-
Bernstein Reiterates Outperform Rating on Mondelez International (MDLZ)
-
CNH Industrial (CNH) PT Lowered to $16 at Bernstein SocGen Group
-
Bernstein Weighs In on CIGNA (CI) Stock Following Shields Investment
-
Bernstein Reiterates Outperform Rating on On Holding AG (ONON)
-
RELX Plc. (REL:LN) (RELX) PT Raised to GBP43.45 at Bernstein SocGen Group
-
Bernstein SocGen Group Upgrades Wolters Kluwer NV (WKL:NA) (WTKWY) to Outperform
-
Bernstein SocGen Group Starts Bullish (BLSH) at Market Perform
-
How much will dollar retailers benefit from store closures?
-
Orsted stock: What is the risk-reward for investors now?
-
Bernstein sees an 'enhanced buying opportunity' in this medical devices stock
-
UnitedHealth Group (UNH) PT Raised to $379 at Bernstein
-
Bernstein Weighs In on The Hotel Opportunity for Airbnb Inc. (ABNB)
-
Lululemon Athletica Inc. (LULU) PT Lowered to $220 at Bernstein
-
Broadcom Limited (AVGO) PT Raised at Bernstein Following Strong AI Revenues

